Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hans J, Kolmos"'
Autor:
Rune M. Pedersen, Rasmus B. Grønnemose, Kristian Stærk, Cecilie A. Asferg, Thea B. Andersen, Hans J. Kolmos, Jakob Møller-Jensen, Thomas E. Andersen
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 8 (2018)
Most bacterial infections initiate at the mucosal epithelium lining the gastrointestinal, respiratory, and urogenital tracts. At these sites, bacterial pathogens must adhere and increase in numbers to effectively breach the outer barrier and invade t
Externí odkaz:
https://doaj.org/article/4670cd2ed77a4695a7679f360292331d
Autor:
Mette, Bjerre, Jørgen, Hilden, Jens, Kastrup, Maria, Skoog, Jørgen F, Hansen, Hans J, Kolmos, Gorm B, Jensen, Erik, Kjøller, Per, Winkel, Allan, Flyvbjerg, Christian, Gluud
Publikováno v:
Bjerre, M, Hilden, J, Kastrup, J, Skoog, M, Hansen, J F, Kolmos, H J, Jensen, G B, Kjøller, E, Winkel, P, Flyvbjerg, A, Gluud, C & Claricor Trial Group 2014, ' Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial ', Scandinavian journal of clinical and laboratory investigation, vol. 74, no. 8, pp. 657-64 . https://doi.org/10.3109/00365513.2014.930510
Bjerre, M, Hilden, J, Kastrup, J, Skoog, M, Hansen, J F, Kolmos, H J, Jensen, G B, Kjøller, E, Winkel, P, Flyvbjerg, A, Gluud, C & CLARICOR Trial Group 2014, ' Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease : The CLARICOR trial ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 74, no. 8, pp. 657-664 . https://doi.org/10.3109/00365513.2014.930510
Bjerre, M, Hilden, J, Kastrup, J, Skoog, M, Hansen, J F, Kolmos, H J, Jensen, G B, Kjøller, E, Winkel, P, Flyvbjerg, A, Gluud, C & CLARICOR Trial Group 2014, ' Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease : The CLARICOR trial ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 74, no. 8, pp. 657-664 . https://doi.org/10.3109/00365513.2014.930510
Objectives. To elucidate the prognostic power of serum osteoprotegerin (OPG) in patients with stable coronary artery disease (CAD). Methods. Serum OPG levels were measured in the CLARICOR trial cohort of 4063 patients with stable CAD on blood samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2e8175f3a2ffa1cb653dbe9ab53ca4
